Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Spatiotemporal-controlled ultrasound-driven Li-PDA@ZnO nanoparticles promote neural stem cell differentiation synergy with biohydrogel repair spinal cord injury

Zhang D., Zhou X., Zhao C., Han S., Guo X., Chen H.

Animal Study on Spinal Cord Injury, published in Bioact Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Bioact Mater (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41078864
PMCID
PMC12513234
DOI
10.1016/j.bioactmat.2025.07.050
Citations
5

Abstract (original English)

Neuronal loss following spinal cord injury (SCI) remains a significant barrier to the recovery of neural function. Neural stem cells (NSCs) supplementation offers a promising therapeutic avenue by providing seed cells; however, the differentiation rate of NSCs into neurons is often suboptimal. In this study, lithium was immobilized on the surface of ZnO nanoparticles using a polydopamine coating to synthesize Li-PDA@ZnO nanoparticles. These nanoparticles were designed to induce NSC differentiation into neurons in a spatiotemporal-controlled manner using ultrasound-driven stimulation. Additionally, a biohydrogel system consisting of genipin and collagen was developed to encapsulate NSCs preloaded with endocytosed nanoparticles. The application of ultrasound stimulation to ZnO nanoparticles enhanced the differentiation of NSCs into neurons in a concentration-dependent manner following endocytosis. Li-PDA@ZnO nanoparticles demonstrated improved biocompatibility and further promoted neuronal differentiation, a process mediated by molecular pathways involving ERK and ASCL1. In vivo, the ability of ultrasound-driven nanoparticles to enhance NSC differentiation was validated using a mouse SCI contusion model. Furthermore, the combined nanoparticle-biohydrogel system was evaluated in an SCI transection model, where it was found to reduce local inflammation, enhance neuronal differentia

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research